Breaking News

Tweet TWEET

Arrowhead to Present at Upcoming Scientific Conferences

  Arrowhead to Present at Upcoming Scientific Conferences

18th Annual Meeting of the RNA Society 4th RNAi Research & Therapeutics
Conference European CLINAM and ETPN Summit

Business Wire

PASADENA, Calif. -- June 13, 2013

Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics
company, today announced that the company will present data on the Dynamic
PolyConjugate™ (DPC) siRNA delivery system and the ARC-520 hepatitis B drug
candidate at three upcoming scientific conferences.

Scheduled conference presentations in June include the following:

The 18th Annual Meeting of the RNA Society – Davos, Switzerland, June 14, 2013

A workshop presentation titled, “Development of Dynamic Polyconjugates for
tissue-targeted delivery of siRNA,” will be presented by Christine Wooddell,
Ph.D., Senior Scientist;

4th RNAi Research & Therapeutics Conference – San Francisco, CA, USA, June 21,
2013

A featured presentation titled, “DPC Technology for siRNA Delivery: Moving
from Platform to Pipeline,” will be presented by David Lewis, Ph.D., Vice
President, Biology;

The European CLINAM and ETPN Summit, Clinical Nanomedicine and Targeted
Medicine – Basel, Switzerland, June 26, 2013

An oral presentation titled, “A Novel Hepatitis B Treatment with RNAi,” will
be presented by Christopher Anzalone, Ph.D., President and CEO.

About Arrowhead Research Corporation

Arrowhead Research Corporation is a clinical stage targeted therapeutics
company with development programs in oncology, obesity, and chronic hepatitis
B virus. The company is leveraging its platform technologies to design and
develop peptide-drug conjugates (PDCs) that specifically home to cell types of
interest while sparing off-target tissues, create targeted drugs based on the
gene silencing RNA interference (RNAi) mechanism, and work with partners to
create improved versions of traditional small molecule drugs.

For more information please visit http://www.arrowheadresearch.com, or follow
us on Twitter @ArrowRes. To be added to the Company's email list to receive
news directly, please send an email to ir@arrowres.com

Contact:

Arrowhead Research Corporation
Vince Anzalone, CFA
626-304-3400
or
The Trout Group
Lauren Glaser
646-378-2972
ir@arrowres.com
 
Press spacebar to pause and continue. Press esc to stop.